NCT03401515

Brief Summary

Traumatic Brain Injury (TBI) is one of the leading causes of death. Severe TBT is correlated with an exaggerated stress response due to plasma catecholamine levels known as sympathetic storming. It is also autonomic dysfunction syndrome. This phenomenon is also associated with brain tumors, severe hydrocephalus and subarachnoid hemorrhage. Patients are presented by tachycardia, tachypnea hypertension, diaphoresis, dystonia, hyperthermia, and dilated pupils with elevated levels of plasma catecholamine and blood glucose .

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Oct 2016

Shorter than P25 for phase_4

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 21, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 17, 2018

Completed
Last Updated

January 17, 2018

Status Verified

January 1, 2018

Enrollment Period

8 months

First QC Date

November 21, 2017

Last Update Submit

January 16, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • catecholamine level

    Norepinephrine plasma levels in pg./ml

    7 days

Secondary Outcomes (1)

  • Temperature

    7 days

Study Arms (2)

Intervention

ACTIVE COMPARATOR

Adminstration of propranolol hydrochloride ( 1 MG /ml) 1 mg every 6 hrs .

Drug: Propranolol Hydrochloride 1 MG/ML

Control

PLACEBO COMPARATOR

Adminstration of normal saline 1 mg every 6 hrs

Other: Normal saline

Interventions

Propranolol 1 mg every 6 hrs in the first 24 hrs after isolated blunt traumatic brain injury

Intervention

Normal Saline 1 ml every 6 hrs

Control

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with isolated blunt TBI
  • From 18 to 60 years old both sex
  • Not in need of mechanical ventilation
  • GCS on admission between 9 and 12
  • Rotterdam CT score from 2-4.
  • Normal Procalcitonin test to exclude infection.

You may not qualify if:

  • Preexisting heart disease
  • Myocardial injury
  • Craniotomy
  • Preexisting cerebral dysfunction
  • Spinal cord injury
  • Diabetes mellitus
  • Severe liver or kidney disease
  • Patients with sepsis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Brain Injuries, Traumatic

Interventions

PropranololSaline Solution

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

PhenoxypropanolaminesPropanolaminesAmino AlcoholsAlcoholsOrganic ChemicalsPropanolsAminesNaphthalenesPolycyclic Aromatic HydrocarbonsHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsPolycyclic CompoundsCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of anesthesia,intensive care and pain management

Study Record Dates

First Submitted

November 21, 2017

First Posted

January 17, 2018

Study Start

October 1, 2016

Primary Completion

June 10, 2017

Study Completion

August 1, 2017

Last Updated

January 17, 2018

Record last verified: 2018-01